Malignant Reproductive System Neoplasm — Trials

Malignant Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,804
Recruiting: 1,546
Ph III recruiting: 175
Growth YoY: +16.2%
Industry share: 21%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,473)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03393962	Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors	enrolling by invitation	Phase 1 / Phase 2	20	Shenzhen Geno-Immune Medical InstituteOTHER	1	Jun 23, 2026	clinicaltrials
NCT05570994	177Lu-HTK03170 in mCRPC With PSMA Positive Disease	enrolling by invitation	Phase 1 / Phase 2	50	British Columbia Cancer AgencyOTHER	1	Jan 8, 2026	clinicaltrials